Vutrisiran

Amvuttra

25 MG / 0.5 ML SolutionCanadaMarketedAuthorised 15 Dec 2023

In other countries

The same active substances on other registers, the same brand first.

AmvuttraBrazil · Specialty Pharma Goias LtdaSame brand
Amvuttra 25 MG Solucion Inyectable en Jeringa PrecargadaSpain · 25 mg · solución inyectable en jeringa precargada · Alnylam Netherlands B.V.Same brand
Amvuttra 25 MG Solucion Inyectable en Jeringa PrecargadaSpain · 25 mg · solución inyectable en jeringa precargada · Alnylam Netherlands B.V.Same brand
AmvuttraEuropean Union · Alnylam Netherlands B.V.Same brand
AmvuttraCroatiaSame brand
AmvuttraItaly · Soluzione iniettabile in siringa pre-riempita · Alnylam Netherlands BVSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vutrisiran

Amvuttra

25 MG / 0.5 ML SolutionCanadaMarketedAuthorised 15 Dec 2023

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Amvuttra 25mg, oplossing voor injectie in voorgevulde spuit

Netherlands · Oplossing voor injectie · Alnylam Netherlands B.V.

Amvuttra solution for injection in pre-filled syringe 25mgSingapore · 25mg · injection, solution · Medison Pharma Singapore Pte. LTD.

AmvuttraUnited States · 25MG BASE/0.5ML · solution · Alnylam Pharms INC

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Vutrisiran
Strength: 25 MG / 0.5 ML
Dosage form: Solution
Route: Subcutaneous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 15 Dec 2023
Registration: DIN 02542420
Marketing authorisation holder: Alnylam Netherlands B.V.
ATC code: N07XX18
Group: Nervous system
Supply: PRESCRIPTION